HOME >> MEDICINE >> NEWS
Unexpected benefit seen in treating HER-2 breast cancer with new preoperative drug combo

HOUSTON - A new use of the drug Herceptin appears to offer a much more powerful treatment advantage than expected for patients with HER-2-positive breast cancer, say researchers at The University of Texas M. D. Anderson Cancer Center.

When combined with chemotherapy and used before surgery in early stage breast cancer the drug proved so beneficial - eliminating 42 percent more tumors than chemotherapy alone - that the clinical trial testing of this new treatment plan was halted early, the researchers report in the Journal of Clinical Oncology.

"This is a far better result than we had anticipated and seems to suggest that simultaneous use of chemotherapy and Herceptin offers a much more potent treatment than use of these drugs sequentially, or alone," says lead investigator Aman Buzdar, M.D., professor in the Department of Breast Medical Oncology at M. D. Anderson.

"This is the best treatment result we have seen in this patient population," Buzdar says. "It shows that we can potentially change the natural history of a disease that is associated with a high risk of recurrence and death."

He cautions, however, that although this combination of therapies seems to show better efficacy, as well as less risk of heart damage than has been seen before with Herceptin treatment, "the jury is still out on the long-term safety and outcome. As in all such studies, we will need to wait years to follow the progress of our patient participants," Buzdar says.

Details of the trial result, slated for the June issue of the journal, were posted online Feb. 28 because of interest in the study. Preliminary results of the trial were presented in June, 2004 at the annual meeting of the American Society of Clinical Oncology.

After only 34 of a planned 164 patients had completed therapy, the trial's Data Monitoring Committee stopped the clinical trial because of the obvious benefit seen in patients who received Herceptin and chemotherap
'"/>

Contact: Nancy Jensen
nwjensen@mdanderson.org
713-792-0655
University of Texas M. D. Anderson Cancer Center
29-Mar-2005


Page: 1 2 3 4

Related medicine news :

1. Unexpected similarities between raindrops and proteins
2. Unexpected target may unlock the door to fighting sepsis
3. Corrected metabolism leads to health benefits and weight loss
4. Two years after gene therapy treatments, severe angina patients showed prolonged clinical benefit
5. Artery clearing system does not provide benefit for patients undergoing PCI
6. Older women can benefit from chemotherapy to treat breast cancer
7. Flu vaccination benefits people of any age with high-risk medical conditions
8. Clinical breast examination offers modest benefit to breast cancer screening program
9. Patients with previous heart attacks may not benefit from pacemaker implant
10. Computer memory, MRI technology benefit from student research at UH
11. Clinical trial of Etanercept for Wegeners disease shows no benefit

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/22/2019)... ... 21, 2019 , ... Desert Pines Equine Medical & Surgical Center ... practices. The deal closed on September 20th, 2019. , “We’re very excited to ... Pines Equine Medical & Surgical Center. “We are on our way to building a ...
(Date:11/22/2019)... ... ... Benchmark Senior Living , a human connection company and leading provider of ... of the Top Places to Work for the 12th straight year in The Boston ... made the list every year it has been published and is the only senior ...
(Date:11/22/2019)... PETERSBURG, Fla. (PRWEB) , ... November 21, 2019 ... ... company, announced that it has received DEA approval to ship THC and CBD ... plant extract derivatives from the marijuana plant containing THC and CBD. MMJ will ...
(Date:11/22/2019)... ... 2019 , ... Serving Seniors , the nonprofit organization dedicated to helping ... annual employee-based survey project from The San Diego Union-Tribune. , Founded in 1970, ... nearly 50 years. From senior advocacy and mental health programming to housing and nutritional ...
(Date:11/22/2019)... ... ... Acclaimed actor from “The Matrix,” “Contagion,” and “Mystic River,” Laurence Fishburne, is ... a teaching tool for its viewing audience and covers a wide variety of topics ... taken on a journey into the world of medical technology. The upcoming episode will ...
Breaking Medicine News(10 mins):
(Date:11/22/2019)... ... 21, 2019 , ... Dr. Braden Josephson joins Centria Autism ... and overseeing the Centria clinical staff by championing quality, fostering clinical effectiveness and ... delivery of clinical services. , Prior to joining the Centria team, Dr. Josephson ...
(Date:11/22/2019)... ... November 21, 2019 , ... ... will attend the Radiological Society of North America’s (RSNA) 105th Scientific Assembly and ... Mindray will unveil its newest product and highlight its diverse portfolio of radiological ...
(Date:11/22/2019)... Mich. (PRWEB) , ... November 21, 2019 , ... ... Nurse Practitioner, has successfully met the criteria and has passed the examination necessary ... is North America’s leading nonprofit organization dedicated to improving health and quality of ...
Breaking Medicine Technology:
Cached News: